This new book discusses the extent to which the Japanese economy encourages entrepreneurship and innovation.
Although Japan has a strong reputation as an innovator, some people argue that this reputation is misplaced. Contrary to earlier expectations, the USA rather than Japan emerged as the leader in the biotech industries in the 1990s, and also many small firms in Japan supply only a few – or just one – other company, thereby limiting their view of the marketplace and the commercial opportunities within it. Despite the increase of international patents, international scientific citations and a positive technology trade balance, the Japanese innovation system is weak in giving birth to radical innovations.
The book explores fully these issues, making comparisons with other countries where appropriate. It concludes that the Japanese innovation system has both advantages and disadvantages and contributes to a better understanding of how policy changes take place.
|Publisher:||Taylor & Francis|
|Series:||Routledge Contemporary Japan Series , #5|
|Product dimensions:||6.25(w) x 9.25(h) x 0.60(d)|
Table of Contents
List of figures vii
List of tables ix
Notes on contributors xi
Small firms and innovation policy in Japan: an introduction Cornelia Storz 1
Shift in policy changes 11
How do we formulate policies? The problem of defining policies and their evaluation Lambert T. Koch 13
Japanese science and technology policy in transition: from catch-up orientation to frontrunner orientation Martin Hemmert 33
Innovation policy for SME in Japan: the case of technology transfer centres Klaus Ruth 56
Cognitive models and economic policy: the case of Japan Cornelia Storz 82
The shift in entrepreneurial behaviour in SMEs 109
Restructuring the Japanese national biotechnology innovation system: prospects and pitfalls Reiko Kishida Leonard H. Lynn 111
Supplier system and innovation policy in Japan Hiroshi Ueno Takashi Murakoso Takumi Hirai 137